Epidemiology, risk factors and prevention

• Secondary Prevention of Coronary Heart Disease is Less Agressive in Patients Over 64 Years

  Miguel A Muñoz, Jaume Marrugat

  Rev Esp Cardiol. 2003;56:586-93

• Cardiopulmonary Function and Exercise Capacity in Patients With Morbid Obesity

  Luis Serés, Jordi López-Ayerbe, Ramón Coll, Oriol Rodríguez, José M Manresa, Jaume Marrugat, Antonio Alastrue, Xavier Formiguera, Vicente Valle

  Rev Esp Cardiol. 2003;56:594-600

• Comparative Study of the Impact of Diet Versus Pravastatin on Color Vision in Brodman Area 19 Detected by Computerized Chromatic Analysis (CARDIOCOLOUR Study)

  Antonio Alcalá, Miguel Morell, Francisca Rius

  Rev Esp Cardiol. 2002;55:1243-50

• Methods of Reporting Research-Results and their Influence on Decision-Making by Cardiologists Prescribing Drugs for Primary and Secondary Prevention

  Carlos Brotons, Irene Moral, Aida Ribera, Purificación Cascant, Manuel Iglesias, Gaietà Permanyer-Miralda, Ignacio Ferreira González, Jordi Soler-Soler

  Rev Esp Cardiol. 2002;55:1042-51

• New Data on Secondary Prevention of Myocardial Infarction in Spain. Results of the PREVESE II Study

  José A de Velasco, Juan Cosín, José Luis López-Sendón, Eduardo de Teresa, Manuel de Oya, Guillermo Sellers

  Rev Esp Cardiol. 2002;55:801-9

• Epidemiology of Ischaemic Heart Disease in Spain: Estimation of the Number of Cases and Trends from 1997 to 2005

  Jaume Marrugat, Roberto Elosua, Helena Martí

  Rev Esp Cardiol. 2002;55:337-46

• Changes in the Clinical Profile of Patients Treated with Oral Anticoagulants During the Decade of the Ninety

  Eduardo Vázquez Ruiz de Castroviejo, María José Martín Barranco, Antonio Martín Rubio, Antonio Fajardo Pineda, Cristóbal Lozano Cabezas, Manuel Guzmán Herrera, Ada Tarabini Castellani, Carlos Pagola Vilardebó, Eufrasio Martínez Galiano, Antonio Alcalá Muñoz

  Rev Esp Cardiol. 2002;55:55-60